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Minutes of the Meeting 
 
The Department of Health and Human Services (HHS) and the Centers for Disease 
Control and Prevention (CDC) convened a meeting of the Advisory Committee on 
Childhood Lead Poisoning Prevention (ACCLPP).  The proceedings were held on 
March 18, 2003 at the Hilton Crystal City Hotel in Arlington, Virginia.  The following 
individuals were present to contribute to the discussion. 
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Mr. Timothy Morta  Executive Secretary 
Mr. Kent Taylor  
ACCLPP Ex-Officio/Liaison Members  
Presenters and Guests Mr. Byron Bailey (HRSA) 
Dr. John Borrazzo (USAID) Dr. Craig Boreiko (International Lead 
Dr. Patricia Clutton (CPSC)  Zinc Research Organization, Inc.) 
Ms. Olivia Harris (ATSDR) Mr. Rick Fenton (Centers for Medicare 
Dr. David Jacobs (HUD)  and Medicaid Services) 
Dr. Ezatollah Keyvan (CSTE) Ms. Leslie Nickel (Arnold & Porter) 
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Mr. Ronald Morony (EPA)  Shapiro, Morin & Oshinsky) 
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Dr. Michael Weitzman 
  (University of Rochester) 
Ms. Megan Wilson 
 (U.S. Environmental Protection Agency) 
 
Opening Session.  Dr. Carla Campbell, the ACCLPP Chair, called the meeting to order 
at 8:48 a.m.  She welcomed the attendees to the proceedings and opened the floor for 
introductions. 
 
Update on Lead Poisoning Prevention Branch (LPPB) Activities.  Dr. Patrick 
Meehan, the ACCLPP Executive Secretary, announced that Dr. Mary Jean Brown was 
appointed as the new LPPB Chief and will begin serving in this position in June 2003.  
She is well recognized in the lead poisoning prevention field and has been a major 
contributor in this area for a number of years. 
 
Ms. Bonnie Dyck of LPPB reported that HHS established a goal for CDC to eliminate 
childhood lead poisoning as a major public health problem in the United States by 2010.  
The Lead Contamination Act of 1998 authorized the HHS Secretary through CDC to 
award grants to state and local health agencies for comprehensive programs.  These 
initiatives are designed to screen infants and children for elevated blood lead levels 
(EBLLs); ensure  lead poisoned infants and children are given referrals for medical and 
environmental interventions; provide education about childhood lead poisoning; and 
implement core public health functions, including policy development, program 
assessment and quality assurance. 
 
CDC grantees are required to create screening policies or guidelines; develop 
surveillance systems at state or jurisdiction levels to assess the prevalence of childhood 
lead poisoning; monitor the effectiveness of programs; and review trends of local 
screening rates.  The National Childhood Lead Poisoning Prevention Program 
(NCLPPP) will be reauthorized in 2005, but its funding mechanism was changed in 
2000 from grants to cooperative agreements.  This mechanism allows CDC to establish 
more collaborative relationships with states and local jurisdictions.  NCLPPP currently 
funds 43 states, nine cities and eight counties. 
 
Although childhood lead poisoning is a preventable environmental disease, data from 
federal studies showed the following results:  434,000 children were lead poisoned; 
21.9% of African-American children in older housing had EBLLs; 16% of low-income 
children in older housing were lead poisoned versus 2.2% of all children; and 1.2 million 
homes with significant lead-based paint hazards housed low-income families with 
children <6 years of age.  LPPB conducts several activities in an effort to address these 
issues.  Health departments at state and local levels as well as tribal health authorities 
are awarded funds to implement core public health functions and conduct a variety of 
services, including screening, medical and environmental case management, health 




Childhood lead poisoning surveillance programs at national and state levels; public and 
professional health education and communication activities; and CLPPP quality 
assurance projects are developed and implemented.  Partnerships are built and linked 
with state CLPPPs, community-based organizations and federal agencies to prevent 
and control lead hazards in high-risk areas.  Scientific studies are performed on blood, 
environmental lead, laboratory technologies, handheld analyzers and dust wipe 
analyzers.  Epidemiological research is conducted as well.  Policy statements and 
guidance documents are developed.  Financial support is provided through cooperative 
agreements and supplemental funding. 
 
Technical assistance and consultation are offered to state and local CLPPPs.  Support 
is provided for primary prevention activities, laboratory capacity, new technologies and 
quality control initiatives.  Several state grantees are performing surveillance studies to 
examine screening rates among children enrolled in Medicaid and the Women, Infants 
and Children (WIC) program.  Collaborative efforts are undertaken with managed care 
organizations (MCOs), interdepartmental projects and interagency activities on an 
ongoing basis.  Healthy Homes, surveillance studies and other special projects are 
conducted.  Childhood lead poisoning prevention education activities are designed and 
implemented. 
 
In FY’03, CDC will allocate ~$31 million to fund 43 states, local programs, territories and 
federally recognized Indian tribes.  Of these grantees, five will be local jurisdictions with 
the largest number of children who are at risk for lead exposure.  The major 
requirements outlined in the FY’03 program announcement are the development of 
childhood lead poisoning elimination plans, targeted screening approaches, surveillance 
systems, case management guidelines, strategic partnerships, protective policies, 
primary prevention projects and evaluation plans.  Grantees will also be required to 
coordinate activities with agencies involved in lead hazard reduction programs. 
 
At a minimum, state grantees will be required to develop, implement and evaluate 
statewide screening plans; adopt ACCLPP’s case management guidelines; and design 
statewide elimination plans to determine the amount of screening needed to meet the 
federal definition of <1% of lead poisoned children .  FY’03 funding will be allocated on 
July 1, 2003; grantees will be given one year from that time to meet the minimum 
requirements.  LPPB established several priorities in the FY’03 program announcement.  
Funding will be provided to state and local CLPPPs.  Guidance and technical assistance 
will be given for CLPPPs to define populations of children at risk for lead poisoning, 
assess prevalence rates within jurisdictions, identify lead poisoning sources, and link 
resources that can be used to develop lead-safe environments for children. 
 
Regional training workshops will be held on the new case management guidelines 
developed by ACCLPP for CLPPPs to ensure appropriate medical and environmental 
case management is provided to children with EBLLs.  Ms. Patricia McLaine, an 
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ACCLPP liaison representative, will lead these sessions.  Community-based support for 
lead poisoning prevention efforts will be encouraged.  Statewide surveillance systems 
will be enhanced through capacity building initiatives.  Collaborative efforts will be 
undertaken with several partners to educate health care providers, MCOs, insurers, real 
estate brokers, parents and the general public about childhood lead poisoning.  During 
CDC’s strategic planning meeting in December 2002, several key recommendations 
emerged:  The National Electronic Disease Surveillance System (NEDSS) should be 
supported within states.  Primary prevention activities should be improved by tracking 
and monitoring housing with data collected by the U.S. Department of Housing and 
Urban Development (HUD).  Advocacy for Healthy Homes projects and lead-safe 
housing should be strengthened.  Private and federal resources should be maximized to 
allocate more funding to states and local jurisdictions.  Media advocacy training should 
be provided to state and local CLPPPs.  A forum for lead poisoning researchers should 
be convened each year.  A Blue Ribbon Committee of lead poisoning prevention 
experts should be established to travel to states and local jurisdictions to build 
programmatic capacity.  Consideration should be given to adding a question on housing 
conditions to the U.S. Census. 
 
Dr. Pamela Meyer of LPPB provided an overview of surveillance activities.  To monitor 
progress toward meeting the 2010 goal of eliminating childhood lead poisoning, LPPB is 
using data from several sources.  The National Health And Nutrition Examination 
Survey (NHANES) is an excellent tool that examines trends at the national level and 
identifies EBLL risk factors, i.e., race/ethnicity, income, age of housing and Medicaid 
enrollment.  These data indicate that BLLs among children 1-5 years of age are 
decreasing nationwide.  In January 2003, CDC released the Second National Report on 
Human Exposures to Environmental Chemicals.  The document was developed using 
NHANES to assess exposure of the U.S. population to environmental chemicals using 
biomonitoring.  The lead section of the report contains geometric mean BLLs and an 
estimate of the prevalence of EBLLs among young children in the United States. 
 
CDC monitors trends at state and local levels using state surveillance data collected by 
CLPPPs.  Some CLPPPs use the CDC developed patient tracking software, the 
Systematic Tracking of Elevated Lead Levels And Remediation (STELLAR), which can 
transmit lead surveillance data to CDC.  However, many states have developed their 
own tracking systems.  LPPB is developing a new patient tracking system which can be 
used with NEDSS, the new web-based disease reporting system that CDC is 
developing.  NEDSS will facilitate timely reporting and improve capacity of state and 
local health departments to access child demographic, laboratory and environmental 
investigation data.  NEDSS may also serve as an initial step in improving access to both 
health and environmental data. 
 
For example, many states have not integrated health and environmental databases.  
LPPB is closely collaborating with the CDC Environmental Tracking Branch, which is 
developing a tracking system that integrates data about environmental hazards and 
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exposures with data about diseases that are possibly linked to the environment.  The 
new lead module in NEDSS should enable CLPPPs to collect more complete data to 
achieve the following objectives:  provide accurate information; assess the effectiveness 
of data for program evaluation; collect data on a more frequent basis, such as two to 
four times per year rather than annually; improve data quality; encourage states to use 
lead data for childhood lead poisoning elimination; and issue reports and other 
publications.  LPPB is preparing a surveillance report for publication in the Morbidity and 
Mortality Weekly Reports (MMWR) Surveillance Summaries. 
 
The modified NEDSS system will also be used to verify the accuracy of data submitted 
to CDC by states, particularly the number of children screened and tested.  Efforts are 
currently being made for laboratories to submit electronic reports to NEDSS as well.  In 
September 2002, LPPB held a meeting with two representatives from each of its 60 
grantees to prioritize issues that need to be addressed to improve surveillance data 
needed for achieving elimination.  Participants made the following recommendations:  
target areas with the greatest need; use data to appropriately allocate resources; track 
children on an ongoing basis; develop a uniform reporting system; establish strong 
partnerships at state and local levels; and provide states with NEDSS, Geographic 
Information Systems and other state-of-the-art technologies. 
 
Over the past eight months, two workgroups have been developing strategies to 
improve the quality of surveillance data, including developing standard definitions, 
creating guidelines for releasing surveillance data, and improving data linkages among 
Medicaid, WIC and environmental agencies.  In addition to these activities, LPPB 
implemented another strategy as part of its elimination efforts.  The High Intensity 
Targeted Screening (HITS) project, which featured door-to-door screening in high-risk 
areas, was implemented in two Chicago neighborhoods in 2001.  LPPB used a 
population-based survey to assess prevalence and validate prevalence estimates of 
children with EBLLs obtained with Chicago CLPPP surveillance data.  The initiative 
generated a great deal of interest and support from the community and local legislators.  
However, because this approach is so resource intensive, HITS should only be 
replicated in areas with a large population of high-risk children, an established 
screening program, an existing case management strategy, capacity for environmental 
inspections and a HUD partner. 
 
Of 535 children tested in HITS, 98% were African American; 70% were enrolled in 
Medicaid; 96% of children 1 year of age had not been tested and 74% of children 2 
years of age had not been tested.  The prevalence of BLLs >10 Fg/dL was found to be 
33% in one Chicago community and 23% in the other neighborhood. 
 
The epidemiology and surveillance section is preparing to evaluate many CLPPP 
activities and plans, including screening plans, targeting interventions, case 




Dr. Banner inquired about the number of states that are expected to comply with the 
new funding requirements in the one-year deadline.  He pointed out many lead 
programs have suffered resource deficits.  Ms. Dyck did not believe the one-year time-
line will be an issue since 83% of states have already developed screening policies and 
guidelines.  Dr. Harvey emphasized the need for ACCLPP to discuss and clarify “level 
of concern” and “lead poisoned.”  For example, in CDC’s 1991 and 1997 guidance 
documents, a BLL of 15 Fg/dL was the level of concern for an individual child and 10 
Fg/dL was the level of concern if lead poisoning was relatively prevalent in the 
community.  ACCLPP’s 1996 recommendation for lead poisoned to be defined as a BLL 
of 10 Fg/dL was rejected.  However, CDC is now basing its statewide elimination plans 
on a BLL of 10 Fg/dL.  Dr. Meehan agreed with Dr. Harvey’s comments because CDC 
has not yet established official definitions for “elimination” and “lead poisoned.”  
However, he added that this issue is currently being considered by the Strategic 
Planning Workgroup. 
 
Dr. Binns noted that many state program leaders have limited knowledge of current 
research in the published literature.  She made two suggestions to address this issue.  
First, abstracts of funded programs should be posted on the LPPB web site.  Second, 
support should be provided for grantees to conduct monthly Medline searches.  The 
literature reviews should be widely publicized to ensure all programs remain up-to-date 
on current studies. 
 
In response to Ms. Guthrie-Wengrovitz, Ms. Dyck confirmed that LPPB will consider 
whether the strategic plan should be distributed to ACCLPP for review and comment.  
Mr. Timothy Morta of LPPB conveyed that the FY’03 program announcement has a 
stronger focus on primary prevention.  Five project officers provide technical assistance 
to 60 currently funded CLPPPs.  Due to this guidance, he was confident that grantees 
will have the ability to comply with new program requirements of developing evaluation, 
screening, case management and elimination guidelines. 
 
Dr. Hoffman advised CDC to test HITS with an epidemiological approach to ensure 
children with actual EBLLs are identified in a high-risk area.  He noted that the project 
was conducted without a control group in a low-risk community.  Dr. Meehan reiterated 
that HITS is extremely resource-intensive.  As a result, LPPB is discussing the 
possibility of performing a cost analysis to determine the feasibility of CLPPPs 
conducting HITS.  Although no control group was used, the major outcome from the 
project was that a significant proportion of children in the Chicago communities had 
never been screened.  Dr. Rogan saw the need to apply an established survey research 
methodology in which children are sampled from a known population to estimate true 
prevalence.  With this approach, every child in an area would not need to be identified.  
He pointed out that differences in prevalence among geographic areas have not been 




Ms. Guthrie-Wengrovitz inquired about the percentage of HITS homes that were 
assessed for lead hazards and treated.  She also asked about the proportion of children 
who received interventions to prevent EBLLs.  She was extremely concerned that HITS 
was merely implemented as a research project rather than a prevention effort to assist 
high-risk children.  Dr. Meyer replied that HITS children were retested after the study 
and attempts were made to perform follow-up environmental inspections. 
  
Dr. Piomelli was pleased that HITS was conducted as a house-to-house intervention to 
identify at-risk children.  Most notably, children of illegal immigrants are most severely 
lead poisoned and will never present to a physician for screening due to fear of 
authorities.  ACCLPP’s responsibilities should be to discontinue support of lead 
research, advocate for action and strongly encourage CDC to continue with door-to-
door screening.  Dr. Campbell questioned whether LPPB will provide technical 
assistance for states to advance to a universal reporting system.  Dr. Meyer responded 
that CDC has written letters to grantees emphasizing the importance of reporting all 
BLLs. 
 
Dr. Hoffman mentioned that the new lead component of NEDSS will be an improvement 
over STELLAR, but additional refinements still need to be made.  A web-based system 
allows real-time access data and CDC should stop thinking linearly, i.e., only accessing 
data two to four times per year.  With this strategy, CDC and grantees would have the 
capacity to simultaneously share and access data at all times instead of transferring 
data from local programs to states to CDC.  Ms. McLaine was pleased that LPPB has 
strengthened its focus on evaluation.  States should be required to produce more 
information on screening plans; barriers to screening; laws requiring laboratories to 
report all BLLs; and the effectiveness of case management in assisting children with 
EBLLs and remediating homes with lead hazards.  These data will be critical in 
monitoring progress toward elimination. 
 
Ms. McLaine urged CDC to maintain the evaluation component as a high priority in the 
FY’03 program announcement.  Dr. Lynn pointed out that data on the frequency 
distribution of EBLLs were not mentioned in either of the presentations.  This 
information will play an important role in evaluating the problem of EBLLs at the national 
level.  Dr. Meyer confirmed that these data will be reported in LPPB’s surveillance 
summary scheduled for publication in the MMWR in late summer 2003.  Dr. Binns 
advised LPPB to send a letter to all state grantees about the degree to which reporting 
BLLs and accessing medical records will be impacted by the Health Insurance 
Portability and Accountability Act of 1996 (HIPAA).  Dr. Meyer acknowledged that CDC 
is in the process of determining the role of HIPAA on lead programs.  The programmatic 
impact will primarily depend on the interpretation of this regulation by states. 
 
Update by the Workgroup on Review of Evidence for Effects at BLLs <10 Fg/dL.  
Dr. Michael Weitzman, the Workgroup Chair, explained that the workgroup was formed 
because previous guidance indicated adverse health effects might occur at BLLs <10 
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Fg/dL.  The workgroup was charged with reviewing existing evidence to confirm or 
refute these guidelines.  Dr. Weitzman, in conjunction with the ACCLPP Chair and CDC 
staff members, selected the following workgroup members:  Drs. David Bellinger, Birt 
Harvey, Betsy Lozoff, Patrick Parsons, David Savitz, Joel Schwartz and Kimberly 
Thompson.  The diverse membership represents a wealth of experience in lead, 
laboratory issues, pediatrics and epidemiology.  Over the past year, the workgroup has 
held one face-to-face meeting and convened more than six conference calls. 
 
The workgroup considered several issues that play a role in causal inferences, including 
biologic plausibility, blood lead tracking, age trends and potential confounders from 
social or physical environments.  These factors may include iron status, maternal 
prenatal smoking, postnatal environmental tobacco smoke (ETS) and mouthing 
behavior.  In reviewing both epidemiologic studies and animal data, the workgroup 
noted several key issues that will need to be addressed.  First, animal studies are 
problematic because the process to make inferences across species is difficult and 
methodologies to expose animals and children are different. 
 
Second, data are lacking on whether a critical period of vulnerability exists during a 
particular point in a child’s life.  The literature does not clarify whether the most essential 
component in a child’s development is a peak BLL or duration of exposure to lead.  
Third, mouthing behavior was evaluated in previous studies, but is not being actively 
investigated.  The lack of current data will significantly increase the difficulty in making 
this assessment.  Fourth, blood lead measurements, accuracy and precision may not be 
reliable due to variability among laboratories.  Fifth, the quality of neurobehavioral 
assessments is questionable because several different tests have been used to date. 
 
The workgroup reviewed a published paper that relied on NHANES data to show an 
association between BLLs of children >6 years of age and achievement test outcomes.  
The workgroup is uncertain whether concurrent or earlier BLLs acted as a predictor of 
decreased IQ points, but upcoming longitudinal studies are expected to explain the 
importance of blood lead tracking and age trends.  The workgroup originally decided to 
limit its review to peer-reviewed papers of substantial numbers of children with BLLs 
<10 Fg/dL.  These data would also contain published results that assessed the 
relationship between BLLs and outcomes at levels <10 Fg/dL.  However, the workgroup 
soon learned that only a small amount of studies meet these criteria because children 
with BLLs <10 Fg/dL are a relatively recent phenomenon. 
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Based on this finding, the workgroup revised its approach to include studies of postnatal 
lead exposure and intelligence with a minimum of 10 children with BLLs <10 Fg/dL.  
Under the new criteria, the data will assess BLLs by atomic absorption, spectrometry 
and anodic stripping voltammetry and will also evaluate health outcomes beyond 
neurocognition and behavior, including nerve conduction, hearing, height and onset of 
adolescence.  The workgroup has discussed the possibility of conducting a meta-
regression analysis to explore threshold and other causal inferences.  Differences in the 
 
slope of the relationship between IQ and BLLs at <10 Fg/dL and >10 Fg/dL are being 
considered as well.  Variations in methodologies, study designs, outcome measures 
and study samples to pool data are being noted. 
 
Despite the complexities of the literature and the large number of articles that need to 
be reviewed, the workgroup has made tremendous progress to date.  Key issues have 
been identified and assigned to workgroup members with the most expertise in the 
respective field.  A background paper has been drafted, reviewed and repeatedly 
revised based on comments from workgroup members.  A matrix of postnatal blood 
lead intelligence studies is currently being developed.  Data retrievals from the 
published literature and articles in press are still underway.  The workgroup expects to 
present the first draft report to ACCLPP by June 2003 and hopes to receive comments 
in July 2003.  The document will be revised based on ACCLPP’s comments and 
redistributed in September 2003.  The second draft will be discussed by ACCLPP 
during the October 2003 meeting. 
 
In response to Dr. Banner, Dr. Weitzman confirmed that the workgroup is examining the 
relationship between EBLLs and alcohol exposure.  Dr. Hoffman inquired about the 
correlation between the workgroup’s activities and those of the Primary Prevention 
Workgroup.  Dr. Tom Matte of CDC explained that if the evidence shows adverse health 
effects can occur at BLLs <10 Fg/dL, the need to take a primary prevention approach by 
focusing on housing and other sources of lead exposure will be strengthened. 
 
In response to Dr. Lynn, Drs. Weitzman and Matte clarified the workgroup’s charge.  
The magnitude of adverse health effects at BLLs <10 Fg/dL will be reviewed and 
quantified, but definitive answers are not expected to be produced.  The review is being 
conducted to demonstrate the quality and limitations of the current evidence and show 
progress that has been made since the 1991 statement was issued.  Dr. Campbell 
added that after the workgroup’s report is presented to ACCLPP during the October 
2003 meeting, a decision will need to be made on whether formal recommendations 
should be developed or further actions should be taken.  This objective could be 
achieved through several mechanisms. 
 
For example, a workgroup could be formed to interpret results of the evidence, write a 
report outlining the conclusions of the review or develop policy recommendations.  Dr. 
Rogan asked if the workgroup has access to primary data on children with BLLs <10 
Fg/dL.  Dr. Matte emphasized that the workgroup will not review primary data, but 
another group plans to examine this evidence.  However, the ACCLPP workgroup will 
review cross-sectional studies that average BLLs <10 Fg/dL. 
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Update on Medicaid Targeted Screening Recommendations.  Dr. Meehan 
mentioned that LPPB made a commitment to ACCLPP to closely collaborate with 
appropriate partners to ensure the Medicaid targeted screening recommendations are 
reviewed, seriously considered and implemented.  After ACCLPP submitted the 
 
guidelines to the HHS Secretary in September 2002, CDC and the Centers for Medicare 
and Medicaid Services (CMS) formed a workgroup to review the recommendations, 
formulate a strategy and develop an implementation plan.  Both agencies are in 
complete agreement that states should be allowed to target populations for screening to 
improve screening rates among Medicaid children so long as data support this effort. 
 
To date, the interagency workgroup has held three telephone conferences and one 
internal meeting.  CDC and CMS will continue to collaborate to develop an approach 
that is effective for both agencies.  The implementation strategy will be refined, 
presented to the HHS Operation Divisions and eventually forwarded to the HHS 
Secretary.  CDC and CMS do not have a written proposal or recommendations to share 
with ACCLPP at this time, but the agencies hope to present a formal process at the next 
meeting in October 2003.  Mr. Rick Fenton of CMS confirmed that the agencies are 
making strong efforts to finalize a strategy to implement ACCLPP’s recommendations. 
 
Dr. Harvey raised the possibility of CDC recommending that states conduct 
epidemiologic studies to identify Medicaid children who should and should not be 
screened.  To assist in the decision-making process, CDC could provide a strong 
epidemiologic basis or background data to states requesting waivers.  States could then 
use this information to develop screening plans and appropriately target children within 
the Medicaid population.  Dr. Meehan conveyed that in the FY’03 cooperative 
agreements, LPPB will emphasize targeted screening for Medicaid children.  This effort 
will be consistent with the overall objective for states to obtain the best information and 
use data as effectively as possible.  LPPB is closely collaborating with states to improve 
analyses of available housing, census and screening data. 
 
Efforts are also being made for states to develop screening and elimination strategies 
that are based on solid data.  This type of logical approach will eliminate the need to 
screen every child and direct resources to areas with the greatest need.  Dr. Banner 
disagreed with Dr. Harvey’s suggestion because epidemiologic studies will overlook at-
risk children in Oklahoma and other rural states.  These types of data will most likely 
conclude that EBLLs are not a problem.  A focused screening strategy should be 
developed to identify children with diffuse health problems in rural areas.  Dr. Meehan 
agreed with this recommendation because a large number of providers in Oklahoma 
and other rural states ignore the mandatory universal screening requirement due to the 
small number of children who present with EBLLs. 
 
Dr. Campbell advised the interagency workgroup to thoroughly review ACCLPP’s report 
to the HHS Secretary while developing the implementation strategy.  The document 
outlined data needs for Medicaid targeted screening in great detail.  With this approach, 
CDC and CMS will be less likely to duplicate the excellent product developed by 
ACCLPP.  Ms. Guthrie-Wengrovitz followed up on this comment by volunteering the 
Medicaid Screening Workgroup to assist the agencies in developing the strategic plan.  
The workgroup could also recommend field personnel who can clarify issues the 
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interagency workgroup is currently considering.  Dr. Piomelli agreed with ACCLPP’s 
approach to screen Medicaid children, but he underscored the importance of including 
other poor children who are excluded from this population.  For example, many 
immigrants may not have sufficient education or English speaking skills to apply for 
Medicaid.  
 
Update on Screening of Immigrant and Adopted Children.  Ms. Nikki Kilpatrick of 
LPPB reported that ACCLPP submitted a letter to the HHS Secretary emphasizing the 
importance of educating health care providers and parents of immigrants, refugees and 
internationally adopted children about potential lead hazards.  The letter also 
underscored the need to screen these populations for lead poisoning.  LPPB has taken 
the following actions to date in response to the letter.  The U.S. Department of State 
(DOS) and Office of Consular Affairs were contacted to devise an effective mechanism 
to disseminate information to parents who enter the country with young children.  LPPB 
is requesting assistance from ACCLPP in identifying points of contact for these 
agencies. 
 
In the interim, LPPB will distribute the parent letter ACCLPP developed and other 
materials to consulate offices throughout the country and foreign medical physicians 
who administer tests to incoming children.  These providers are certified by CDC and 
may serve as a tool to more broadly circulate the ACCLPP parent letter.  LPPB also 
needs assistance in identifying a partner in the Immigration and Naturalization Services.  
The agency was relocated in the Office of Homeland Security and its focus on 
immigrant health issues may have changed with the reorganization. 
 
In contacting the DOS Bureau of Refugee and Migration Services, LPPB learned that 
refugees entering the United States are assigned to one of ten voluntary agencies.  
These organizations assist with the reception, placement and community orientation of 
refugees; testing and other health issues are covered in these sessions.  LPPB also 
learned that ~66% of states have a refugee coordinator who establishes guidelines for 
refugee health issues.  The president of an organization representing state coordinators 
was contacted to assist in disseminating the ACCLPP parent letter.  The Joint Council 
on International Children’s Services was contacted as well.  This organization 
establishes guidelines for state-regulated international adoptions and also collects and 
distributes information to international adoption clinics, federal agencies and child 
welfare service bureaus. 
 
The web sites of 19 international adoption clinics in the United States were reviewed.  
All of these resources emphasize the need to conduct lead screening of children 
adopted from certain countries.  For children of refugees and immigrants, ACCLPP’s 
recommendations will be reinforced to health care providers and nurse practitioners.  To 
further communicate the guidelines, LPPB will tailor ACCLPP’s parent letter to specific 
target audiences and distribute the document to state and local health departments, 
federal agencies, non-profit organizations and grantees.  The CDC Yellow Book is 
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targeted to travelers and a section on international adoptions and lead poisoning was 
incorporated into the 2003-2004 edition. 
 
The next steps in this project will be for LPPB to distribute explanatory letters and 
parent letters to various organizations.  Information about the impact of lead poisoning 
on refugee, immigrant, and internationally adopted children will also be posted on the 
LPPB web site.  Information about ACCLPP has now been added to the CDC web site 
and can be accessed at www.cdc.gov/nceh/lead/ACCLPP/acclpp_main.htm.  The 
roster, charter, workgroups, recommendations, meeting minutes and upcoming meeting 
schedules are outlined on the new web page. 
 
Dr. Campbell commended LPPB on its diligent efforts in making contacts and 
disseminating ACCLPP’s parent letter.  Dr. Piomelli reiterated that children of illegal 
immigrants have the highest proportion of lead poisoning, but have been excluded from 
screening activities.  Dr. Binns advised LPPB to contact Federally Qualified Health 
Centers since these agencies provide care to illegal and uninsured immigrants.  Dr. 
Jacobs added that HUD and the Department of Justice issued policy guidance making 
Lead Hazard Control Grant Program services accessible to illegal immigrants.  Dr. 
Banner committed to providing Ms. Kilpatrick with a list of emergency physicians since 
emergency departments serve as the only source of care for many Hispanic immigrants.  
Guidance to these providers should emphasize the importance of screening this 
population of children, particularly new arrivals to the United States. 
 
Study of Relationship Between ETS and BLLs.  Dr. David Mannino of CDC explained 
that tobacco smoke contains >4,000 different substances, including combustion 
products, particulate matter, pollutants, lead, cadmium and other metals.  Several 
critical factors are considered when smoke exposure is measured in individuals, such 
as the volume of space in which smoke is dispersed, ventilation and removal of 
pollutants.  These components then follow a pathway of concentration of smoke in an 
air space, exposure of persons breathing in the air space, individual breathing rates, 
airway geometry, dose, individual capacity to metabolize or eliminate smoke, 
biologically effective dose, and health effects.  Age, presence of underlying disease and 
other susceptibility factors play a role in the pathway from ETS exposure to health 
effects. 
 
Data on ventilation adjusted by age and weight show that children are disproportionately 
more exposed to air pollutants than adults.  To measure smoke exposure, 
questionnaires, measurements of air pollutants and biomarkers can be used.  Cotinine 
is a metabolized product of nicotine and is the best and most frequently used biomarker 
of tobacco smoke exposure.  Cotinine has a half-life in blood of 15-40 hours and can be 
measured in serum, urine, saliva and hair; 80% of nicotine is metabolized to cotinine.  
Lead was a focus of CDC’s study due to its presence in processed tobacco and tobacco 
smoke.  Lead also has a relatively long half-life of 30-200 days in blood.  NHANES data 
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show that a comparison of reported and measured smoke exposure is problematic, but 
conclusions have been made from research conducted to date. 
 
Lead levels in ambient air and tobacco have been decreasing over time.  The lead level 
in each cigarette is 1-5 Fg/g; 1%-8% passes into smoke.  Lead levels in ambient air 
were 22 ng/m3 in homes where smoking was allowed.  Gastrointestinal absorption of 
lead is 50% in children versus 10%-15% in adults; pulmonary absorption of lead is 
>50% in children compared to 30%-50% in adults.  The objective of CDC’s study was to 
determine whether smoke exposure was related to EBLLs.  The analysis was limited to 
a subset of 5,592 children 4-16 years of age with available serum cotinine levels 
reported in NHANES data.  BLLs were measured with standard methods and a limit of 
detection of 1 Fg/dL. 
 
Reported exposure to ETS was defined as the total number of cigarettes smoked in the 
child’s household per day.  No ETS exposure was defined as no persons in the 
household smoked.  Any ETS exposure was defined as at least one individual in the 
household smoked.  Cotinine levels were measured with atmospheric pressure 
ionization tandem mass spectrometry and a limit of detection of 0.050 ng/mL.  
Covariates included in the analysis were race/ethnicity, region of country, 
socioeconomic status and demographics, i.e., parental education level, poverty level, 
age of housing, gender, family size, number of persons and rooms in the household, 
and age of child.  Analytic methods included weights to reflect national estimates; SAS 
and SUDAAN software; predictors of BLLs >10 Fg/dL; and regression models to 
examine the relationship between smoke exposure and BLLs. 
 
Children in the study were divided into a high exposure group of >20 cigarettes daily; a 
medium exposure group of 1-19 cigarettes daily; and a low exposure group of no daily 
cigarettes.  The majority of children in the study were white and lived in housing built 
after 1973.  The data showed the following results:  ~15%-20% of children with the 
highest measured cotinine levels had no reported smoke exposure; ~35% of children 
had reported smoke exposure in the home.  As expected, children with higher cotinine 
levels had significantly higher BLLs than children with no exposure.  Higher BLLs were 
also found among children who were black, younger, poorer, resided in older or smaller 
homes, lived in Northeastern states and had parents with lower education levels. 
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Of all study participants, 4% had BLLs >10 Fg/dL.  This subset primarily resided in 
Northeastern and Midwestern states.  The cohort was also stratified into three age 
groups of 4-6 years, 7-11 years and 12-16 years.  Children who admitted to actively 
smoking and those with cotinine levels >15 were excluded from the study.  The 
strongest effect of EBLLs was seen in the youngest age group and among black 
children.  No white children with low cotinine levels had EBLLs.  Based on uni-variate 
and multi-variate models, children with high exposure to tobacco smoke had 60% and 
40%, respectively, higher BLLs than those with low-level exposure.  Multi-variate 
models showed an odds ratio of 20 for BLLs >10 Fg/dL among the 4-6 year age group; 
 
the odds ratio decreased in older children.  Overall, the study was unable to definitively 
address several important issues: 
 
• The relationship between prenatal and postnatal exposure. 
• The contribution of tobacco smoke exposure to EBLLs. 
• The importance of lead in ambient air as an exposure source for children. 
• The ability of lead in tobacco smoke to increase BLLs to this extent. 
• Absorption, metabolism or other important factors that may play a critical 
role. 
• Results in the intermediate exposure group in which tobacco exposures 
were low and BLLs were high. 
• The role of tobacco smoke as an important confounder in studies of lead 
exposure and cognitive outcomes. 
 
The study concluded that children with recent ETS exposure as defined by cotinine 
levels have increased BLLs.  Lead may be a useful biomarker of smoke exposure, but 
more research needs to be conducted.  Dr. Mannino announced that the paper is 
currently in press in Epidemiology and is expected to be published by September 2003. 
 
Dr. Banner emphasized the need to focus on other illicit substances that are smoked in 
the environment and cause second-hand exposure.  For example, children are 
presenting with positive screens of methamphetamine, cocaine and other substances 
that may be caused by dust on surfaces or passive inhalation.  Dr. Jacobs asked if 
housing ventilation systems were examined in the study.  Dr. Mannino replied that this 
factor was not analyzed due to the lack of solid data.  However, size of home was 
included as a confounder and is the best surrogate of housing ventilation system.  To 
further address this issue, CDC has collected data on apartment buildings to determine 
exposure outcomes when residents share air spaces. 
 
Dr. Rogan asked if data are available on the amount of lead in air produced by smokers.  
He raised the possibility of CDC also examining children’s exposure to lead from food 
handled by smokers.  Dr. Mannino responded that data indicate as much as 300 ng/m3 
of lead is in air.  Dr. Matte noted that the relationship between age of housing and BLLs 
was more significant in the group with higher cotinine levels than children with lower 
cotinine levels.  He also pointed out that the effect of cotinine on average BLLs was 
greater in children who lived in older housing than those who lived in newer homes.  Dr. 
Mannino agreed with these observations because the data showed that ETS enhanced 
older housing, poverty and other traditional risk factors for lead exposure.  Mr. Goldman 
questioned whether the study examined the relationship between diet and smoking 
since unhealthy eating habits create a higher uptake of lead. 
 
Dr. Mannino mentioned that this factor was not included in the study.  However, he 
acknowledged that diets tended to be poorer among families with more passive smoke 
exposure than those with no ETS.  The relationship between diet and smoking is 
Page 14 
 
explored in-depth in another CDC paper that will soon be published in Nicotine and 
Tobacco.  Overall, the data did not demonstrate that diet is a major factor in the 
correlation between ETS exposure and EBLLs.  Dr. Weitzman raised the possibility of 
reviewing earlier NHANES data when BLLs and cotinine levels were higher.  Dr. Harvey 
asked if data have been collected on the relationship between cotinine levels and 
postnatal IQ in children.  Dr. Weitzman replied that one study estimated a loss of 4.5 IQ 
points for every 10 cigarettes the mother smoked.  Dr. Banner indicated that the Primary 
Prevention Workgroup should consider focusing on the reduction of ETS exposure in 
terms of lead. 
 
Update by the Primary Prevention Workgroup.  Dr. Campbell reported that the 
workgroup was formed 16 months ago and is now presenting the seventh draft of the 
primary prevention document to ACCLPP for review and comment.  The workgroup 
plans to submit the document to a medical editor for further refinements.  The current 
draft reflects general recommendations made by ACCLPP during previous meetings:  
rewrite the document with a stronger focus; incorporate additional references; clarify the 
target audience; include more data on enforcement strategies and incentives; ensure 
the terminology is consistent throughout the document; and provide information about 
other sources of lead for children, but maintain the focus on housing. 
 
The workgroup is recommending that the document be issued as a standalone 
publication.  A shorter journal article targeted to pediatricians, family practitioners, public 
health professionals, housing personnel and other specific audiences should also be 
released to compliment the main document.  To more widely publicize primary 
prevention and obtain endorsement beyond HHS, ACCLPP has been invited to present 
the document at the next meeting of the Interagency Federal Task Force on Lead 
Poisoning Prevention in May 2003.  Dr. Campbell and Ms. Amy Murphy, the workgroup 
chair, will most likely represent ACCLPP at the meeting. 
 
Another activity to advance the workgroup’s efforts is Building Blocks for Primary 
Prevention:  Protecting Children from Lead-Based Paint Hazards.  CDC has allocated 
funding to the Alliance to End Childhood Lead Poisoning to implement the project.  The 
purpose of the initiative is to cite examples of primary prevention strategies that have 
been implemented and make these models available to jurisdictions throughout the 
country.  The Alliance is tentatively scheduled to make a presentation on the project 
during the ACCLPP meeting in October 2003.  A summary of the project and Alliance’s 
paper on Making Lead-Safe Housing the Central Focus of Strategic Plans to Eliminate 
Childhood Lead Poisoning are collectively appended to the minutes as Attachment 1. 
 
In an effort to move toward consensus of the primary prevention document, Dr. 
Campbell asked ACCLPP to make specific and concrete comments.  She reminded the 
members that the primary target audience is health environmental and housing 
professionals at state and local levels.  A shorter document was also distributed that 
serves as a preface.  She conveyed that the workgroup is discussing the possibility of 
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developing a glossary to clarify terms.  Dr. Campbell mentioned that a workgroup 
meeting is scheduled on the following day for further editing of the document.  
Comments made during the discussion by ACCLPP members are outlined below. 
 
• Rewrite the document to be less bureaucratic, more concise and with a 
stronger focus.  Emphasize the primary prevention message and clarify 
the purpose of the document.  Include a section that explicitly states 
primary prevention extends beyond screening and an active search should 
be conducted in communities to identify high-risk children. 
 
• Revise the technical language and concepts into laymen’s terms since the 
document also serves as a marketing tool for communities, legislators and 
health care providers. 
 
• Outline solutions that can now be taken to reduce risks of lead exposure 
to children, i.e., improving diets and overall health, reducing ETS, 
enforcing regulations and remediating homes with lead hazards.  Use this 
approach to partner rather than compete with the Vaccines For Children 
Program and other federal initiatives that focus on childhood health. 
 
• Delete “primary prevention” and strengthen the focus on housing issues.  
For example, the document could be renamed as Prevention of Lead 
Poisoning in Young Children Associated with Housing Exposures. 
 
• Remove non-housing lead exposures from the primary prevention 
document.  Cite the ACCLPP case management document and other 
references for other lead sources. 
 
• Reformat the eight key elements in the text box summary, narrative, 
subcategories and Appendix 5 to be parallel in all sections of the 
document. 
 
• Strengthen political will for primary prevention by including the cost-benefit 
to society and offering incentives to landlords.  This approach will 
minimize resistance by property owners to shift to a primary prevention 
strategy. 
 
• Redefine the target audience as CLPPPs and state and local health 
departments.  Provide practical guidance for grantees to effectively 
implement the eight elements of a comprehensive primary prevention 
childhood lead poisoning program.  Distribute detailed and concrete 
recommendations and other tools to assist grantees in better responding 
to the FY’03 program announcement and effectively interacting with 
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housing agencies to implement the primary prevention guidelines.  Issue a 
shorter document in the future to submit to journals. 
 
• Decide on the publication venue and then format the document 
accordingly. 
 
• Refrain from using “lead-safe” because the term de-emphasizes the need 
for continued maintenance of an abated home and implies intact lead is 
safe. 
 
• Separate key roles and responsibilities of health and housing departments 
in Appendix 5 because these agencies have completely different missions 
and functions. 
 
• Provide explicit guidance, particularly for tasks that will require extensive 
resources and political support.  For example, the establishment of a 
statewide regulatory structure at the state level and enforcement of 
housing standards at the local level are recommended on page 22, but no 
advice is provided for CLPPPs and housing agencies to conduct these 
activities. 
 
• Avoid presenting a detailed implementation strategy for each guideline in 
the document.  Present the recommendations as options for CLPPPs to 
address local problems with appropriate partners, including housing 
agencies, health departments, legislators, insurance companies and 
landlords. 
 
• Emphasize the critical role of landlords in the shift to primary prevention.  
For example, 95% of landlords in a Maryland Eastern Shore county 
adhered to the new legislation to register all rental properties built before 
1950.  The high compliance rate is due to the belief by these landlords 
that protection of children and safe properties are important. 
 
• Develop an appendix of model state laws for CLPPPs to present to state 
legislators and health departments.  Other resources that could be 
included in the appendix are contact information for national agencies and 
relevant web sites.  Appropriately reference these resources in the 
document as “(see resource X).” 
 
• Reword the document to recommend that CLPPPs “initiate” statutory and 
regulatory guidelines rather than “take the lead.” 
 
• Revise the introduction to immediately identify the target audience; explain 
the intended use of the document; emphasize the need for health and 
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housing agencies to closely collaborate; and recommend that CDC 
grantees begin to shift the focus from secondary to primary prevention.  
Integrate the standalone preface into the main primary prevention 
document. 
 
• Modify the document based on ACCLPP’s most recent comments.  
Authorize LPPB staff and contract editors to refine the revised draft. 
Distribute the document to three to five CLPPPs for review and comment 
and circulate this feedback to ACCLPP.  Distribute this version to 
ACCLPP for review and comment before the document is placed for a 
vote at the October 2003 meeting. 
 
• Ensure that the following statement in the document is accurate and 
supported by data:  The “vast majority” of childhood BLLs >10 Fg/dL is 
associated with exposure to deteriorated lead-based paint and other 
factors. 
 
Several follow-up comments were made in response to the above suggestions.  Dr. 
Jacobs clarified that the document is an attempt to encourage local health and housing 
agencies to prevent exposures and exposure pathways in housing.  This effort is 
consistent with the 1992 Congressional definition of a lead-based paint hazard as 
deteriorated paint and contaminated dust and soil.  The primary prevention document 
offers guidance to local health and housing agencies to make housing safe, conduct 
follow-up of children and intervene before exposures occur.  Several members 
requested that Dr. Jacobs’s comments be formalized and included in the introduction of 
the document. 
 
Dr. Meehan explained the process to finalize the document.  After ACCLPP formally 
approves a draft, LPPB staff and contract editors will further refine the document into a 
professional and high-quality product.  Before additional progress can be made, 
however, ACCLPP must now agree on the target audience and the publication venue.  
For example, CDC’s Reports and Recommendations (R&Rs) are standalone documents 
published in the MMWR.  R&Rs are longer than regular MMWR articles and are broadly 
disseminated to clinicians through web-based subscriptions.  The primary prevention 
document can also be issued as a journal article or standalone publication outside of 
the MMWR. 
 
Dr. Meehan mentioned that resolution of these issues will dictate whether public health 
jargon or laymen’s terms would be more appropriate.  ACCLPP authorized the 
workgroup to define a time-line to finalize the document and circulate a draft to CLPPPs 
for preliminary review and comment.  Agreement was reached to place the document 
for a formal vote by ACCLPP during the October 2003 meeting.  Dr. Jacobs indicated 
that the primary prevention document may need to be distributed before the next 
Page 18 
 
meeting, particularly if CLPPPS will use the guidelines as reference materials for the 
July 1, 2003 cooperative agreement. 
 
Dr. Meehan returned to one of the recommendations and expressed concern with 
ACCLPP formally requesting that CLPPPs shift from screening to primary prevention.  
CDC would be more comfortable with ACCLPP emphasizing the critical role of primary 
prevention in a comprehensive public health program that includes screening, case 
management and other important components.  He explained that CDC is mandated by 
legislation to fund screening programs.  Dr. Campbell clarified that the document 
recommends primary prevention strategies be prioritized since secondary prevention 
efforts have traditionally failed in detecting children with lead exposures and toxicities.  
However, the guidelines do not ask programs to abandon secondary prevention. 
 
For example, continued case management of children with EBLLs is suggested.  The 
document further recommends that resources and staff be redirected as the focus shifts 
from secondary to primary prevention.  Several members returned to the proposed time-
line to finalize the primary prevention document.  Concern was expressed due to the 
three-month delay between the July 1, 2003 program announcement and ACCLPP’s 
formal vote on the draft in October 2003.  Dr. Campbell asked members to consider the 
possibility of approving the document by e-mail, regular mail or conference call.  To 
expedite the approval process, Dr. Harvey suggested that only major changes be 
circulated to the voting members.  ACCLPP passed several consensus 
recommendations to address issues raised during the deliberations. 
 
Ms. Guthrie-Wengrovitz placed the following motion on the floor for a vote.  CLPPPs 
should serve as the primary target audience of the document.  Health agencies, 
community groups and other partners of CLPPPs that will be needed to implement the 
primary prevention recommendations should serve as the secondary target audience.  
The focus of the document should remain on housing-based primary prevention 
interventions.  Ms. Guthrie-Wengrovitz accepted Dr. Campbell’s amendment of the 
motion to also include local and state health departments as a primary target audience, 
particularly agencies without a CLPPP.  The motion was seconded by Dr. Binns and 
unanimously approved with no further discussion. 
 
Dr. Lynn placed the following motion on the floor for a vote.  The primary prevention 
document should be issued as detailed standalone guidelines that can be tailored to a 
shorter and more concise journal article in the future.  The motion was seconded by Dr. 
Binns and unanimously approved with no further discussion. 
 
Dr. Banner placed the following motion on the floor for a vote.  The motion was for 
conditional approval of the present draft of the PPWG document.  The revised primary 
prevention draft should be distributed to voting members via e-mail for further approval 
after further editing by the workgroup, LPPB staff and contract editors.  ACCLPP should 
be provided an opportunity to review and approve the final draft.  The motion was 
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seconded by Dr. Binns and unanimously approved with no further discussion.  Dr. 
Meehan confirmed that all drafts will continue to be circulated to ACCLPP ex officio and 
liaison representatives for review and comment.  He asked non-workgroup members to 
submit additional comments on the document in writing to Mr. Morta. 
 
Potential ACCLPP Priority Topics.  Dr. Campbell reported that two ACCLPP 
workgroups are in the implementation phase, while two others are actively developing 
guidance.  She reviewed a summary of five topics which remained from an ACCLPP 
prioritization process that occurred in February 2001.  The two highest topics, primary 
prevention and review of the evidence for effects at BLLs <10 µg/dL, have already been 
incorporated into workgroups.  Bearing this history in mind, topics that should serve as 
focus areas in the future should now be considered by ACCLPP and LPPB.  Voting 
members will be asked to formally select priority issues either during the October 2003 
or March 2004 meeting.  ACCLPP members’ preliminary suggestions are outlined 
below. 
 
• Formulate guidelines on lead screening of pregnant women to be 
consistent with recommendations that will be issued by another group.  An 
expert panel convened by the Association of Occupational and 
Environmental Clinics is developing medical guidelines for adult lead 
exposures.  Topics on the panel’s agenda include lead exposures during 
pregnancy and nursing, fetal susceptibility, chelation, and working versus 
non-working lead exposures.  Consult with the American College of 
Obstetricians and Gynecologists before developing any guidance related 
to pregnant women. 
 
• Form an ACCLPP workgroup to review available literature on lead 
screening and pregnancy issues.  Present these data to ACCLPP for 
consensus to be reached on whether to place the topic on the overall 
screening and risk assessment agenda at the state level. 
 
• Expand ACCLPP’s lead screening focus to include other heavy metals 
and environmental exposures.  Many states have biomonitoring planning 
grants and will soon be awarded implementation funds.  Collaborate and 
consult with the Adult Medical Guidelines Workgroup, CDC and states in 
focusing on biomonitoring to improve public health. 
 
• Add lead inputs into the environment to the list of priority topics:  lead in 
soil, lead in water, lead in schools, lead in exterior dust and industrial 
sources.  EPA has developed a lead standard for soil, but the problem has 
not been adequately addressed to date.  School districts could benefit 
from solid recommendations on lead from water fountains and other 
sources in public school systems.  Only a minimal amount of data has 
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been collected and published demonstrating the presence of lead in 
exterior dust. 
 
• Use the following criteria to evaluate and select priority topics:  Will HHS/ 
CDC seek advice from ACCLPP on this issue?  Will HHS/CDC have the 
ability to take action on this issue at the policy or program level? 
 
• Form a workgroup of ACCLPP members and outside experts to explore 
international lead issues and the impact on general nutritional status and 
pregnancy.  For example, relief agencies entering Iraq may soon need 
clear guidance on appropriate populations to screen, chelate and treat for 
lead exposures. 
 
• Focus on Healthy Homes since this project is currently generating a fair 
amount of attention among lead programs. 
 
• Distribute guidelines about lead paint to fast-food restaurants, retail store 
chains and other businesses that offer toys to young children. 
 
• Examine the lead exposure situation in the western states 
  
 
Dr. Meehan followed up on some of the proposed priority topics.  First, LPPB will 
continue to closely collaborate and consult with the CDC International Emergency and 
Refugee Health Branch and outside agencies to address issues related to refugees.  
However, LPPB’s funding and appropriations are limited to domestic lead poisoning 
prevention programs.  Second, LPPB has allocated resources and received additional 
funds from HUD to focus on Healthy Homes.  Efforts are currently being made to 
educate CLPPPs about the importance of this initiative. 
 
Drs. Campbell and Lynn noted that refugees, immigrants, pregnant women from certain 
foreign countries, and international adoptees entering the United States have the largest 
burden of EBLLs in most states.  ACCLPP’s efforts in international lead issues would be 
to issue guidance to states from this perspective rather than address EBLLs among 
children overseas.  To assist in this area, Dr. Meyer confirmed that CDC is interested in 
including data on country of origin in the new lead component of NEDSS. 
 
New ACCLPP Business.  The agenda and action items raised during the meeting were 
reviewed and are outlined below. 
 
 Agenda Items 
• Presentation from CDC’s international divisions with responsibility for 
quarantine and immigrant screening prior to U.S. entry.  The overview 
should cover health screening issues along the U.S.-Mexico Border; gaps 
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in current surveillance data; and areas where ACCLPP’s screening 
recommendations could make the most significant impact to CDC. 
 
• Presentation on lead exposures and screening issues related to 
pregnancy. 
 
• Presentation by Dr. Ian von Lindern or the Agency for Toxic Substances 
and Disease Registry on the significant contribution of lead at Superfund 
sites. 
 
• Presentation by Boston and Chicago programs on best practices and 
lessons learned from developing and implementing lead elimination plans. 
 
• Overview by Dr. Brown, the new LPPB Chief. 
 
 Action Items 
• Provide ACCLPP with copies of slides presented by Ms. Dyck and Dr. 
Meyer. 
• Provide ACCLPP with LPPB’s surveillance summary and hard copies of 
the Second National Report on Human Exposure to Environmental 
Chemicals when available. 
• Provide ACCLPP with an electronic version of CDC’s study on the 
relationship between ETS and BLLs after the paper is published. 
• Provide ACCLPP with hard copies of handouts and other meeting 
materials at least one week prior to meetings. 
• Circulate action items to ACCLPP that will require a consensus vote prior 
to meetings.  This approach may assist in ensuring a quorum is 
maintained throughout the duration of the proceedings. 
 
Dr. Borrazzo noted that in the ACCLPP charter scheduled for renewal in 2003, ex 
officios will be granted voting rights.  As a result, votes by ex officios will represent 
agency positions rather than individual perspectives.  This role may complicate the 
voting process for some ACCLPP agenda items.  Dr. Meehan confirmed that this issue 
will be clarified by the CDC Office of General Counsel and Committee Management 
Office prior to the next meeting.  He agreed with Dr. Borrazzo that a large number of ex 
officios may feel uncomfortable representing their respective agencies on certain topics 
and abstain from voting. 
 
Public Comment Period.  The Chair opened the floor for public comments; no 
attendees responded. 
 
Closing Session.  Dr. Campbell encouraged the members to submit detailed 
information for additional agenda items to be considered for the next meeting.  




later than August 2003.  The next ACCLPP meeting will be held on October 14-15, 2003 
in Atlanta, Georgia.  LPPB will poll members via e-mail to determine dates for the 2004 
meetings. 
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